يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"ACF, aberrant crypt foci"', وقت الاستعلام: 0.70s تنقيح النتائج
  1. 1

    المصدر: Translational Oncology, Vol 14, Iss 7, Pp 101089-(2021)
    Translational Oncology

    مصطلحات موضوعية: Oncology, endocrine system diseases, TCF4, Transcription factor 4, Colorectal cancer, RR, relative risk, Review, I2, I-square, HbA1c, Hemoglobin A1c, ADM, antidiabetic medications, AGEs, advanced glycation end-products, SMAD3, Mothers against decapentaplegic homolog 3, US, United States, Impaired glucose tolerance, ADA, American Diabetes Association, Diabetes mellitus, 0302 clinical medicine, GREM1, Gremlin 1, SEPT9, septin 9, RC254-282, APC, Adenomatous polyposis coli, pCR, pathologic complete response, RFS, recurrence-free survival, Metformin, 030220 oncology & carcinogenesis, CRC, colorectal cancer, TCF7L2, Transcription Factor 7 Like 2, medicine.medical_specialty, CSCs, cancer stem cells, WNT, Wingless-related integration site, mTOR, mammalian target of rapamycin, BMI, Body mass index, GLUT1, glucose transporter 1, STZ, streptozotocin, EHMT2, Euchromatic Histone Lysine Methyltransferase 2, VEGFR2, vascular endothelial growth factor 2, mCRC, metastatic colorectal cancer, 03 medical and health sciences, NIDDM, non-insulin-dependent diabetes mellitus, PFS, Progression-free survival, ERFC, Emerging Risk Factors Collaboration, PKC, protein kinase C, KRAS, Kirsten rat sarcoma viral oncogene homolog, AKT, RAC-alpha serine/threonine-protein kinase, WFS1, Wolframin ER Transmembrane Glycoprotein, IGF, Insulin-Like Growth Factor, nutritional and metabolic diseases, medicine.disease, PPARG, Peroxisome Proliferator Activated Receptor Gamma, 030104 developmental biology, Hyperglycemia, TCF7L2, Oncological outcome, 0301 basic medicine, Cancer Research, TP53, tumor protein p53, FOLFOX, Folinic acid, Fluorouracil, Oxaliplatin, RPG, random plasma glucose, Cancer risk, DNA, deoxyribonucleic acid, DM, diabetes mellitus, HNF1B, Hepatocyte nuclear factor-1-beta, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, HR, hazard ratios, CENTRAL, Cochrane Central Register of Controlled Trials, GWAS, Genome-wide association studies, IGF1, Insulin-Like Growth Factor 1, HBP, hexosamine biosynthetic pathway, medicine.drug, PI3K, Phosphoinositide 3-kinases, KCNQ1, Potassium Voltage-Gated Channel Subfamily Q Member 1, EMT, epithelial mesenchymal transition, CAMK1D, Calcium/Calmodulin Dependent Protein Kinase ID, TTR, the time to recurrence, 2-h PG, 2-h plasma glucose, OS, overall survival, ROS, reactive oxygen species, IGFBPs, insulin-like growth factor-binding protein, Internal medicine, RAS, Rat sarcoma, medicine, FPG, fasting plasma glucose, PI3K/AKT/mTOR pathway, VTI1A, Vesicle Transport Through Interaction With T-SNAREs 1A, U.S.FDA, United States Food and Drug administration, OGTT, Oral Glucose Tolerance Test, business.industry, IGF2BP2, Insulin Like Growth Factor 2 MRNA Binding Protein 2, ACF, aberrant crypt foci, AMPK, Cancer, BMJ, British Medical Journal, CI, confidence interval, OR, odds ratio, AMPK, AMP-activated protein kinase, DKD, diabetic kidney disease, TP53INP1, Tumor Protein P53 Inducible Nuclear Protein 1, 5-FU, 5-fluorouracil, NEJM, The New England Journal of Medicine, business

  2. 2

    المصدر: Acta Pharmaceutica Sinica. B
    Acta Pharmaceutica Sinica B, Vol 4, Iss 3, Pp 173-181 (2014)

  3. 3
  4. 4
    دورية أكاديمية
  5. 5

    المصدر: Biochimica et Biophysica Acta. Reviews on Cancer, Vol. 1871, No 2 (2019) pp. 434-454
    Biochimica et Biophysica Acta (BBA)-Reviews on Cancer
    Biochimica et Biophysica Acta. Reviews on Cancer

    مصطلحات موضوعية: 0301 basic medicine, AT1R, angiotensin II type 1 receptor, Cancer Research, Signaling pathways, SMILE, simplified molecular-input line-entry system, Polypharmacology, SVM, Support Vector Machine, MANTRA, Mode of Action by NeTwoRk Analysis, Disease, Medical Oncology, Ab, antibody, Computational approaches, Machine Learning, SEA, Similarity Ensemble Approach, sLA, sialyl Lewis-A antigen, 0302 clinical medicine, GWAS, Genome-Wide Association Studies, TKI, tyrosine kinase inhibitors, A-II, angiotensin-II, Medicine, On/off-target effects, NSAID, non-steroidal anti-inflammatory drug, Side effects, Repurposing, ARD, adverse drug reactions, media_common, ddc:615, AMPK, adenosine monophosphate-activated protein kinase, CaPP3, Cancer Prevention Project 3, LINCS, Library of Integrated Network-Based Cellular Signatures, CHAT, cancer hallmarks analytics tool, 3. Good health, Phenotypes, Drug repositioning, Phenotype, TOP2A, Topisomarase 2-α, Oncology, Drug development, COX-2, cyclooxygenase-2, 030220 oncology & carcinogenesis, USPSTF, U.S. Preventive Services Task Force, Colorectal Neoplasms, Chemical genetics, Pl3K, phosphatidylinositol 3-kinase, Drug, media_common.quotation_subject, Repurposing in oncology, Omics, Antineoplastic Agents, Computational biology, Mechanism of action, KEGG, Kyoto Encyclopedia of Genes and Genomes, Article, RAR α, retinoic acid receptor alpha, OS, overall survival, FMCM, Functional Module Connectivity Map, 03 medical and health sciences, ReDo, Repurposing Drugs in Oncology, NTID, narrow therapeutic index drug, DCF, Diclofenac, LBD, literature-based discovery, Genetics, Animals, Humans, FAP, familial adenomatous polyposis, HERV, human endogenous retrovirus, business.industry, ACF, aberrant crypt foci, Cancer, MRC, Medical Research Council, medicine.disease, Colorectal cancer, CRC, colorectal carcinoma, EGFR, epidermal growth factor receptor, ATC, Anatomical Therapeutic Chemical classification, 030104 developmental biology, RRM2, human ribonucleotide reductase 2, FFN, function-function networks, PFS, progression free survival, EMA, European Medicines Agency, GSToP, gene-selection-by-trend-of-progression procedure, PREDICT, PREdicting Drug IndiCaTions, CMap, Connectivity Map, POG, Personalized OncoGenomic, business

  6. 6